Treating coronavirus with prevention-treatment and not with restrictions, little evidence for "Centaurus", says Dr Pana
At this stage of the pandemic, there are no thoughts of imposing new restrictive measures in Cyprus, European University Lecturer and member of the Scientific Advisory Committee Dr Zoe-Dorothea Pana told CNA, noting that prevention and treatment are of paramount importance at this time.
We need to stress to the world in a completely transparent and evidence-based way, she said, that each phase of the pandemic and its management should be different and adapted to the data and the tools we have available.
Domestic data in our country and across Europe, he noted, show that in this phase of the BA4 and 5 wave, is that we have a hypermetastatic strain with hypermetabolicity, increased positivity rates, but without a commensurate increase in critically ill patients reflected in ICU admissions and deaths.
"The data that we have from the OCHS is that at the moment the hospitalization rate of people infected is below 1% but the rate of people infected and ending up in ICUs is also very, very low compared to previous strains and previous phases of the pandemic which is around 1 in 50," he added.
It is very important now and in the future, he noted, "to evaluate very carefully the surveillance data and to delve into qualitative characteristics in terms of hospitalizations because we need to understand what is really the risk in the general population, in high-risk groups for severe coronavirus disease, which essentially to some extent determines the course of the pandemic and the strategy we have to follow."
He noted that the increase in availability of coronavirus beds, which means people who may have mild to moderate infection and need a mild medical care e.g. oxygen administration, antiviral treatment, is "pivotal" within our country's preparedness framework so that even if we have a mild increase in hospitalizations we can adequately cope.
The other thing, he continued, which has to do with the tools and we will be emphasizing in the fall-winter period of next year, has to do with the pillars of treatment that have recently been added to our quiver in terms of pandemic management. "Right now we also have available in Cyprus the two oral, antiviral drugs and one administered in hospitals, which it seems that for vulnerable groups - over 60 years old and for people with chronic underlying diseases - can reduce up to 90% the risk of hospital admission from severe coronavirus disease," he added.
The key to the effectiveness of these drugs, he stressed, is not only to be supported, properly prescribed by doctors but also administered promptly in the first five days after diagnosis of the disease.
Dr Pana said that the European Medicines Agency together with the European Agency for Disease Control and Prevention and the European Commission through the mouthpiece of the Commissioner for Health, said that all the approved vaccines already in circulation in Europe and Cyprus are even now significantly reducing the likelihood of serious disease and therefore immediate vaccination recommendations for a fourth dose can strengthen the body's defences of vulnerable people to prevent them from becoming seriously ill.
"We need to advance the technology and improve existing vaccines not only for the severe disease part but also for infectivity and longer duration of immunity. These are being studied in parallel by the pharmaceutical industry. We expect after September to have at least two adapted vaccines including Omicron strains," he noted.
The other aspect, he continued, has to do with diagnosis, surveillance and tracing, an area in which Cyprus has been successful since the beginning of the pandemic.
He stressed that at this stage when we have such a massive dispersion, there is value in individual responsibility, not in theory but in practice in everyday life.
The virus, Dr. Pana said, will not be eradicated, we will have it around us and we have to find our strategy to live safely.
The Centaur sub-variant
Dr. Pana said there are discussions among scientists across Europe that what has been observed in recent months with the Omicron sub-variant is that the virus is evolving faster than before.
"It appears that "Centaur" is in the broader Omicron family. It is too early to say on the characteristics of this strain how much more infectious and pathogenic it is," he noted.
If it prevails over the previous strain, he added, the point is that there is now a very efficient mechanism to detect early what is happening with respect to the new strains that exist and will exist so that we can make timely decisions whether it's about treatments, vaccination and more.
Source: CNA
Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source